Top Institutions in Ophthalmology - Retinal Diseases
Leading institutions in retinal disease research employ advanced clinical trials, molecular biology techniques, and translational research to develop and evaluate novel therapies such as antisense oligonucleotides targeting fibrotic pathways in retinal diseases.
-
#1
Bascom Palmer Eye Institute
Miami, FL
Bascom Palmer is consistently ranked as a top ophthalmology center with extensive expertise in retinal disease clinical trials and translational research in novel therapies for AMD and DME.
Key Differentiators
- Ophthalmology
- Retinal Diseases
- Clinical Trials
-
#2
Massachusetts Eye and Ear Infirmary
Boston, MA
Known for cutting-edge research in retinal diseases and development of novel molecular therapies including antisense oligonucleotides and biologics targeting fibrosis and inflammation.
Key Differentiators
- Ophthalmology
- Retina
- Translational Research
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute has a robust portfolio of clinical trials in retinal diseases and is recognized for its research in novel therapeutic targets including TGF-β pathways.
Key Differentiators
- Ophthalmology
- Retinal Disease
- Clinical Research
-
#4
Scheie Eye Institute, University of Pennsylvania
Philadelphia, PA
Scheie Eye Institute is noted for its experimental therapeutics research in retinal diseases, including antisense therapies and novel molecular targets for AMD and DME.
Key Differentiators
- Ophthalmology
- Retina
- Experimental Therapeutics
-
#5
Moorfields Eye Hospital
London, England
Moorfields is a leading international center for retinal disease research and clinical trials, with expertise in novel therapies targeting fibrosis and inflammation in AMD and DME.
Key Differentiators
- Ophthalmology
- Retinal Diseases
- Clinical Trials
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







